BEGIN:VCALENDAR
PRODID://WordPress//Event-Post-V5.9.2//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:-0700
DTSTART:19700329T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:19701025T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
SUMMARY:Biofabrication for Bone Regeneration
UID:https://3dheals.com/?p=42293
LOCATION:
DTSTAMP:20260226
DTSTART;TZID=America/Los_Angeles:20260226
DTEND;TZID=America/Los_Angeles:20260226
DESCRIPTION:Bone biofabrication is rapidly moving from experimental scaffolds to
increasingly functional, vascularized bone constructs tailored to
individual patients, with academia leading in new biomaterials,
multi‑material bioprinting, and bone organoids for regeneration and
disease modeling. At the same time, commercial players in bone regeneration
and 3D bioprinting are scaling platforms for patient‑specific grafts and
implants, feeding into a global bone regeneration market of roughly
5.8–6.2 billion USD in 2025 and a broader 3D bioprinting market of about
2.6 billion USD, both projected to grow steadily over the next decade on
the back of orthopedic and dental demand.[Ref] Yet despite impressive
progress, both academic and commercial communities still face major
hurdles, including bioinks with sufficient mechanical strength for
load‑bearing bone, long‑term vascularization and integration,
regulatory pathways, and scalable manufacturing that meets cost and quality
expectations for hospitals and industry partners. These challenges,
together with fast‑growing applications in large bone defect repair,
cranio‑maxillofacial reconstruction, spinal fusion, dental implants, and
in‑vitro bone models for drug testing, make this the right moment to
convene scientists, clinicians, engineers, investors, and entrepreneurs in
a virtual event to share data, stress‑test business models, and build
collaborations that can push bone biofabrication from promising prototypes
into routine clinical and commercial reality.[Ref] 
END:VEVENT
END:VCALENDAR